Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Solomon

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|October 27, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisAlan Solomon
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 13, 2021
Management of AL amyloidosis in 2021Alan Solomon
The New England Journal of Medicine|October 12, 2002
Hereditary amyloidosisAlan Solomon, Per Westermark
Blood|July 11, 2006
Misclassification of amyloidosis is unwarrantedAlan Solomon, Charles L Murphy, Per Westermark
Archives of Pathology & Laboratory Medicine|January 10, 2008
Unreliability of immunohistochemistry for typing amyloid depositsAlan Solomon, Charles L Murphy, Per Westermark
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodiesAlan Solomon, Deborah T Weiss, Jonathan S Wall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4Alan Solomon, Deborah T Weiss, Jonathan S Wall
Tijdschrift Voor Nu[C]Leaire Geneeskunde|July 26, 2013
Development and evaluation of agents for targeting visceral amyloidJonathan S Wall, Alan Solomon, Stephen J Kennel
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 3, 2003
Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerationsPer Westermark, Joakim Bergström, Alan Solomon, et al.
Kidney International|February 26, 2010
Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsiesChristopher P Larsen, Patrick D Walker, Deborah T Weiss, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|October 27, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisAlan Solomon
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 13, 2021
Management of AL amyloidosis in 2021Alan Solomon
The New England Journal of Medicine|October 12, 2002
Hereditary amyloidosisAlan Solomon, Per Westermark
Blood|July 11, 2006
Misclassification of amyloidosis is unwarrantedAlan Solomon, Charles L Murphy, Per Westermark
Archives of Pathology & Laboratory Medicine|January 10, 2008
Unreliability of immunohistochemistry for typing amyloid depositsAlan Solomon, Charles L Murphy, Per Westermark
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodiesAlan Solomon, Deborah T Weiss, Jonathan S Wall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4Alan Solomon, Deborah T Weiss, Jonathan S Wall
Tijdschrift Voor Nu[C]Leaire Geneeskunde|July 26, 2013
Development and evaluation of agents for targeting visceral amyloidJonathan S Wall, Alan Solomon, Stephen J Kennel
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 3, 2003
Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerationsPer Westermark, Joakim Bergström, Alan Solomon, et al.
Kidney International|February 26, 2010
Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsiesChristopher P Larsen, Patrick D Walker, Deborah T Weiss, et al.
Pageof 6